clinafloxacin has been researched along with Disease Models, Animal in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (50.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abe-Higuchi, N; Hara, K; Higuchi, F; Hobara, T; Itoh, Y; Kobayashi, A; Shintaku, T; Suzuki, T; Uchida, S; Watanabe, Y; Yamagata, H | 1 |
| Cabellos, C; Domenech, A; Gudiol, F; Liñares, J; Ribes, S; Tubau, F; Viladrich, PF | 1 |
| Ehrett, S; Friedland, IR; Hickey, S; McCracken, GH; Olsen, K; Paris, M | 1 |
| Desaty, TM; Griffin, TJ; Heifetz, CL; Sesnie, JC; Shapiro, MA | 1 |
| Cohen, MA; Gage, JW; Huband, MD; Roland, GE; Yoder, SL | 1 |
| Coyle, EA; Hershberger, E; Kaatz, GW; Rybak, MJ; Zervos, MJ | 1 |
6 other study(ies) available for clinafloxacin and Disease Models, Animal
| Article | Year |
|---|---|
Hippocampal MicroRNA-124 Enhances Chronic Stress Resilience in Mice.
Topics: Animals; Antidepressive Agents; Depression; Disease Models, Animal; Fluoroquinolones; Food Preferences; Gene Expression Regulation; Glycogen Synthase Kinase 3 beta; Hippocampus; Histone Deacetylases; Imipramine; Male; Mice; Mice, Inbred BALB C; MicroRNAs; Neurons; Oligodeoxyribonucleotides, Antisense; Stress, Psychological; Topoisomerase II Inhibitors | 2016 |
Experimental study of clinafloxacin alone and in combination in the treatment of ciprofloxacin-susceptible and -resistant pneumococcal meningitis.
Topics: Animals; Cerebrospinal Fluid; Ciprofloxacin; Disease Models, Animal; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Fluoroquinolones; Meningitis, Pneumococcal; Microbial Sensitivity Tests; Rabbits; Rifampin; Streptococcus pneumoniae; Teicoplanin; Treatment Outcome | 2003 |
Evaluation of antimicrobial regimens for treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Cefpirome; Ceftriaxone; Cephalosporins; Disease Models, Animal; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Fluoroquinolones; Male; Meningitis, Pneumococcal; Meropenem; Microbial Sensitivity Tests; Penicillin Resistance; Quinolones; Rabbits; Rifampin; Thienamycins; Vancomycin | 1993 |
Comparative therapeutic efficacy of clinafloxacin in a Pseudomonas aeruginosa mouse renal abscess model.
Topics: Abscess; Animals; Anti-Infective Agents; Area Under Curve; Ceftazidime; Cilastatin; Cilastatin, Imipenem Drug Combination; Ciprofloxacin; Colony Count, Microbial; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Combinations; Drug Therapy, Combination; Female; Fluoroquinolones; Half-Life; Imipenem; Kidney; Kidney Diseases; Mice; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolones; Treatment Outcome | 1998 |
Bacterial eradication by clinafloxacin, CI-990, and ciprofloxacin employing MBC test, in-vitro time-kill and in-vivo time-kill studies.
Topics: Animals; Anti-Infective Agents; Bacterial Infections; Ciprofloxacin; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Mice; Microbial Sensitivity Tests; Naphthyridines; Quinolones | 1998 |
Comparison of a rabbit model of bacterial endocarditis and an in vitro infection model with simulated endocardial vegetations.
Topics: Animal Testing Alternatives; Animals; Anti-Infective Agents; Blood Platelets; Cattle; Ciprofloxacin; Disease Models, Animal; Drug Evaluation, Preclinical; Endocarditis, Bacterial; Enterococcus; Fluoroquinolones; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Naphthyridines; Rabbits; Staphylococcus aureus | 2000 |